Each tablet contains 0.5 mg of cabergoline.
Cabergoline is a dopaminergic ergoline derivative with potent and long-lasting dopamine D₂-receptor agonist properties.
Indications
Kabolak is used for the suppression of physiological lactation immediately after childbirth, stillbirth, abortion, or miscarriage. Kabolak is also used in the treatment of dysfunction associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation, and galactorrhea.
Kabolak is used in patients with prolactin-secreting pituitary adenomas (micro- and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome associated with hyperprolactinemia, in patients with underlying primary pathologies affecting the clinical symptoms mentioned above.